Immediate Press release date, Place, Kolkata, 8.3.2025: Recent findings have raised critical questions about the effectiveness of tranexamic acid in preventing maternal hemorrhage after cesarean delivery. A new study suggests that the commonly used medication may not be as effective in reducing the risk of severe bleeding as previously thought.

Dr Megha Khanna is an expert and best lady gynecologist in Kolkata can easily explain how Tranexamic Acid is effective to prevent blood loss after Cesarean Delivery.

Tranexamic acid, an antifibrinolytic agent, is widely administered to reduce blood loss during surgical procedures, including cesarean sections. It has been championed in obstetrics as a potential life-saving drug for preventing postpartum hemorrhage (PPH), a leading cause of maternal mortality worldwide.

However, a new study challenges the assumed benefits of tranexamic acid in cesarean deliveries. Researchers, conducting a rigorous clinical trial, discovered that the drug did not significantly reduce the incidence of hemorrhage compared to a placebo group. The results have shocked many in the medical community, especially given the growing reliance on the drug in high-risk pregnancies.

"While tranexamic acid has shown promise in other surgical settings, its role in cesarean deliveries remains uncertain," said Dr. Emily Harwell, a senior obstetrician involved in the study. "This finding suggests that while the drug may have benefits in some areas, its use in cesarean sections may not offer the protection we once assumed."

The study followed over 2,000 women undergoing elective and emergency cesarean deliveries, measuring blood loss, the need for additional interventions, and the occurrence of complications. Surprisingly, there was no significant difference in outcomes between those given tranexamic acid and those who received the placebo.

Given the widespread use of tranexamic acid to prevent PPH in cesareans, these results may prompt a reevaluation of current clinical practices. As researchers and healthcare providers analyze the findings, questions about the effectiveness of tranexamic acid in obstetrics are likely to lead to further investigations and discussions.

Experts stress that while this study may be a setback, it is a crucial reminder of the importance of continuous research and clinical trials in improving maternal care. The quest to minimize maternal hemorrhage and ensure the safety of mothers during childbirth remains a priority, but this study emphasizes the need for more targeted, evidence-based approaches.

As this topic gains attention, many are left wondering: Could the answer to preventing severe bleeding in cesarean deliveries lie elsewhere? Or is tranexamic acid simply not the answer we thought it was? The medical community now faces the task of reevaluating treatment protocols and exploring new, more effective ways to safeguard maternal health.

For more details Call: 7003638200

Email: [email protected]

visit: https://drmeghakhanna.in/